$0.00
(+0.00%
) Quote details
USD
+$0.00
(+0.00%
)At Close (As of Dec 11, 2025)
$4.47B
Market Cap
36.52
P/E Ratio
0.98
EPS
$38.00
52 Week High
$7.62
52 Week Low
HEALTHCARE
Sector
Sector: HEALTHCARE
Industry: DRUG MANUFACTURERS - SPECIALTY & GENERIC
Indivior PLC is a leading biopharmaceutical company headquartered in North Chesterfield, Virginia, focused on developing innovative treatments for opioid dependence and related disorders. Known for its pioneering work with buprenorphine-based therapies, Indivior aims to improve patient outcomes and tackle the complexities associated with opioid use disorder. The company demonstrates a strong commitment to public health through substantial investments in research and development, reinforcing its position as a transformative leader in addiction treatment. With a comprehensive product portfolio and a dedicated patient-centric approach, Indivior is well-prepared to address the evolving challenges within the healthcare landscape.
LPTX
NVDA
WOK
VSME
PETS
PLUG
ORCL
ASST
KIND
IVP
IRBT
INTC
F
KVUE
TSLA
ADAP
DNN
AAL
AVGO
HOOD
MARA
NFLX
WBD
GOOGL
SOFI
RR
VALE
NIO
T
RGTI
BYND
PLTR
BAC
PFE
HL
ASBP
PLTD
GRAB
BITF
HPE
RKLB
QBTS
RIG
JBLU
AMD
CIFR
AG
CDE
SNAP
MTSR
BTBT
NCLH
IREN
FI
GOOG
NOK
MSFT
HBAN
CCL
PCG
UBER
SMCI
KO
WULF
LUV
SOUN
SMR
CNQ
VZ
CLSK
LPTX
NVDA
WOK
VSME
PETS
PLUG
ORCL
ASST
KIND
IVP
IRBT
INTC
F
KVUE
TSLA
ADAP
DNN
AAL
AVGO
HOOD
MARA
NFLX
WBD
GOOGL
SOFI
RR
VALE
NIO
T
RGTI
BYND
PLTR
BAC
PFE
HL
ASBP
PLTD
GRAB
BITF
HPE
RKLB
QBTS
RIG
JBLU
AMD
CIFR
AG
CDE
SNAP
MTSR
BTBT
NCLH
IREN
FI
GOOG
NOK
MSFT
HBAN
CCL
PCG
UBER
SMCI
KO
WULF
LUV
SOUN
SMR
CNQ
VZ
CLSK